Received May 26, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | tl74y | IM / RA |
Patient received Shingrix dose #1 vaccine and subsequently experienced expected post-vaccination adverse reactions including cough, congestion, fatigue, headache (flu-like symptoms). Symptoms began approximately the night of vaccination (headache) and has lasted from 5/21/26 to 5/26/26 and patient did stay home from work as he still has cough, congestion and is losing his voice. Patient reported that symptoms were moderate. No hospitalization or life-threatening complications reported. Patient advised on symptom management and monitoring.
NONE
Hypertension
Losartan 100mg, Lisinopril 40mg
NKDA